Market Tracker

02/20 1:05pm ET

Merck & Co Inc (NYSE:MRK)

65.39
Delayed Data
As of Feb 17
 +0.13 / +0.20%
Today’s Change
49.63
Today|||52-Week Range
65.87
+11.08%
Year-to-Date
Clovis, Tesaro Soar on Astrazeneca Phase Three News
Feb 17 / TheStreet.com - Paid Partner Content
Health Care ETF Has Been Ailing
Feb 16 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, PNC Financial, Express Scripts, VeriSign an...
Feb 17 / Zacks.com - Paid Partner Content
What's Driving Lilly's (LLY) Shares after 2016 Decline?
Feb 16 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
Feb 17 / Zacks.com - Paid Partner Content
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb 16 / Zacks.com - Paid Partner Content
Teachers Insurance & Annuity Association Of America Buys JPMorgan Chase, Arch Coal, ....
Feb 16 / GuruFocus News - Paid Partner Content
DexCom Is a Great Healthcare Stock to Buy Now
Feb 15 / TheStreet.com - Paid Partner Content
Q4 Earnings Season Scorecard & Top Analyst Reports
Feb 16 / Zacks.com - Paid Partner Content
Another Potential Alzheimer's Disease Treatment Bites the Dust: What's Next?
Feb 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close65.26
Today’s open65.20
Day’s range64.86 - 65.56
Volume9,048,256
Average volume (3 months)11,328,831
Market cap$180.3B
Dividend yield2.88%
Data as of 4:01pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+30.77%
Earnings growth (this year)+1.29%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)+2.67%
P/E ratio33.4
Price/Sales4.12
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.47+0.61%
PFEPfizer0.000.00%
SNYSanofi-0.38-0.87%
GSKGlaxoSmithKline+0.42+1.03%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$39.8B
Annual profit (last year)$5.7B
Net profit margin14.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts